Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
Status: Recruiting
Location: See location...
Intervention Type: Radiation, Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• existing indication for radiation therapy
• minimum age 18 years, no upper age limit
• capacity for consent
• Informed consent
Locations
Other Locations
Germany
University Hospital Tübingen, Department of Radiation Oncology
RECRUITING
Tübingen
Time Frame
Start Date: 2018-05-09
Estimated Completion Date: 2027-05-09
Participants
Target number of participants: 472
Treatments
Experimental: Rectal and anal cancer
In this arm patients with rectal and anal cancer are recruited.
Experimental: Prostate cancer
In this arm patients with prostate cancer are recruited.
Experimental: Head and neck cancer
In this arm patients with head and neck cancers are recruited.
Experimental: Esophageal cancer
In this arm patients with esophageal cancer are recruited.
Experimental: Breast Cancer
In this arm patients with breast cancer are recruited.
Experimental: Central nervous system tutors
In this arm patients with tumors of the central nervous system are recruited.
Experimental: Palliative treatments
In this arm patients with palliative treatments are recruited.
Experimental: Other
In this arm patients with other tumors are recruited.
Experimental: Imaging only
In this arm patients receive only imaging on the MR-Linac
Related Therapeutic Areas
Sponsors
Leads: University Hospital Tuebingen